A combination therapy with mitomycin c, etoposide, doxifluridine and medroxyprogesterone acetate as second line therapy for advanced breast cancer refractory to combination chemotherapy of cyclophosphamide, doxorubicin and 5 fluorouracil

✍ Scribed by Katsumasa Kuroi; Akihiko Osaki; Hiroyuki Kawami; Shigeru Murakami; Tetsuya Toge

• Publisher: Springer Japan
• Year: 1997
• Tongue: English
• Weight: 374 KB
• Volume: 4
• Category: Article
• ISSN: 1340-6868
• DOI: 10.1007/bf02967064